Article ID Journal Published Year Pages File Type
8486329 Vaccine 2018 7 Pages PDF
Abstract
There is a dearth of prospective studies evaluating the risk of developing LRTI following influenza virus infection. Determining the burden of severe LRTI that is attributable to influenza is necessary to estimate the benefits of influenza vaccine on this important public health outcome. Vaccine probe studies are an efficient way to evaluate these questions and should be encouraged going forward.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , ,